Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10824073 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients
Condition: Emesis
Interventions: Drug: Aprepitant;   Drug: dexamethasone

Indicates status has not been verified in more than two years